Μετάβαση στο περιεχόμενο

ΕτικέταNSCLC

Merck’s Keytruda Nabs Another Approval, This One Under FDA’s Real-Time Program

The U.S. Food and Drug Administration (FDA) granted Merck & Co.’s Keytruda another approval, this one in combination with Alimta (pemetrexed) and platinum chemotherapy for first-line treatment of metastatic non-small cell lung cancer (NSCLC), with … Continue Reading Merck’s Keytruda Nabs Another Approval, This One Under FDA’s Real-Time Program